MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants

Major depressive disorder (MDD) is a multifactorial psychiatric disorder with obscure pathophysiology. A biomarker-based approach in combination with standardized interview-based instruments is needed to identify MDD subtypes and novel therapeutic targets. Recent findings support the impairment of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cholewinski, Tomasz, Pereira, Diana, Moerland, Matthijs, Jacobs, Gabriel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558816/
https://www.ncbi.nlm.nih.gov/pubmed/34733478
http://dx.doi.org/10.1177/20451253211036814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558816/
https://www.ncbi.nlm.nih.gov/pubmed/34733478
http://dx.doi.org/10.1177/20451253211036814

Ejemplares similares